enspryng - satralizumab injection, solution
(Satralizumab)Genentech Inc.
Usage: Enspryng treats neuromyelitis optica spectrum disorder (NMOSD) in adults who test positive for anti-aquaporin-4 (AQP4) antibodies.
Medications for Neuromyelitis Optica
4 results
soliris - eculizumab injection, solution, concentrate
(Eculizumab)Alexion Pharmaceuticals Inc.Usage: Soliris treats paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG) in AChR antibody-positive patients aged 6 and older, and neuromyelitis optica spectrum disorder (NMOSD) in AQP4 antibody-positive adults. Not indicated for STEC-HUS.ultomiris - ravulizumab solution, concentrate
(Ravulizumab)Alexion Pharmaceuticals Inc.Usage: Ultomiris treats PNH and aHUS (including complement-mediated TMA) in adults and pediatric patients one month and older. Also indicated for AChR antibody-positive generalized myasthenia gravis and AQP4 antibody-positive neuromyelitis optica spectrum disorder in adults. Not for STEC-HUS.uplizna - inebilizumab injection
(Inebilizumab)Horizon Therapeutics Usa, Inc.Usage: Uplizna treats NMOSD in AQP4 antibody-positive adults, IgG4-related disease in adults, and generalized myasthenia gravis in adults who are AChR or MuSK antibody positive.